4//SEC Filing
DArecca James 4
Accession 0001127602-25-016517
CIK 0000313143other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:35 PM ET
Size
6.6 KB
Accession
0001127602-25-016517
Insider Transaction Report
Form 4
DArecca James
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2025-05-30+12,221→ 34,156 total - Tax Payment
Common Stock
2025-05-30$69.38/sh−5,864$406,844→ 28,292 total
Footnotes (3)
- [F1]Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on May 16, 2022, based on the issuer's total shareholder return relative to that of the companies comprising the S&P MidCap 400 Index for the performance period from May 16, 2022 to May 15, 2025, as certified by the Compensation Committee of the Board of Directors on May 30, 2025.
- [F2]This number includes unvested restricted stock units ("RSUs") previously reported.
- [F3]Represents shares withheld for tax obligations in connection with the vesting of certain PSUs reported in Table I.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001583903
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:35 PM ET
- Size
- 6.6 KB